首页> 外文OA文献 >A supra-cellular model for coupling of bone resorption to formation during remodeling:Lessons from two bone resorption inhibitors affecting bone formation differently
【2h】

A supra-cellular model for coupling of bone resorption to formation during remodeling:Lessons from two bone resorption inhibitors affecting bone formation differently

机译:骨吸收在重塑过程中与骨形成耦合的超细胞模型:两种骨吸收抑制剂对骨形成的影响不同

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The bone matrix is maintained functional through the combined action of bone resorbing osteoclasts and bone forming osteoblasts, in so-called bone remodeling units. The coupling of these two activities is critical for securing bone replenishment and involves osteogenic factors released by the osteoclasts. However, the osteoclasts are separated from the mature bone forming osteoblasts in time and space. Therefore the target cell of these osteoclastic factors has remained unknown. Recent explorations of the physical microenvironment of osteoclasts revealed a cell layer lining the bone marrow and forming a canopy over the whole remodeling surface, spanning from the osteoclasts to the bone forming osteoblasts. Several observations show that these canopy cells are a source of osteoblast progenitors, and we hypothesized therefore that they are the likely cells targeted by the osteogenic factors of the osteoclasts. Here we provide evidence supporting this hypothesis, by comparing the osteoclast-canopy interface in response to two types of bone resorption inhibitors in rabbit lumbar vertebrae. The bisphosphonate alendronate, an inhibitor leading to low bone formation levels, reduces the extent of canopy coverage above osteoclasts. This effect is in accordance with its toxic action on periosteoclastic cells. In contrast, odanacatib, an inhibitor preserving bone formation, increases the extent of the osteoclast-canopy interface. Interestingly, these distinct effects correlate with how fast bone formation follows resorption during these respective treatments. Furthermore, canopy cells exhibit uPARAP/Endo180, a receptor able to bind the collagen made available by osteoclasts, and reported to mediate osteoblast recruitment. Overall these observations support a mechanism where the recruitment of bone forming osteoblasts from the canopy is induced by osteoclastic factors, thereby favoring initiation of bone formation. They lead to a model where the osteoclast-canopy interface is the physical site where coupling of bone resorption to bone formation occurs.
机译:通过骨吸收破骨细胞和骨形成成骨细胞的联合作用,在所谓的骨重塑单元中保持骨基质的功能。这两个活动的结合对于确保骨质补充至关重要,并且涉及破骨细胞释放的成骨因子。然而,破骨细胞在时间和空间上与成熟的成骨成骨细胞分离。因此,这些破骨细胞因子的靶细胞仍然是未知的。对破骨细胞的物理微环境的最新研究表明,一个细胞层衬托着骨髓,并在整个重塑表面上形成了一个冠层,覆盖了从破骨细胞到成骨细胞的整个过程。一些观察表明,这些冠层细胞是成骨细胞祖细胞的来源,因此我们推测它们是破骨细胞成骨因子靶向的可能细胞。在这里,我们通过比较破骨细胞-冠层界面对兔子腰椎中两种类型的骨吸收抑制剂的反应,来提供支持这一假设的证据。双膦酸盐阿仑膦酸盐(一种导致低骨形成水平的抑制剂)减少了破骨细胞上方的冠层覆盖程度。这种作用是根据其对骨碎裂细胞的毒性作用而定的。相比之下,odanacatib(一种保留骨骼形成的抑制剂)会增加破骨细胞-冠层界面的范围。有趣的是,这些不同的作用与这些相应治疗过程中骨吸收后骨形成的速度有关。此外,冠层细胞显示出uPARAP / Endo180,一种能够结合破骨细胞提供的胶原蛋白的受体,据报道介导成骨细胞的募集。总体而言,这些观察结果支持了一种机制,其中破骨细胞因子诱导了冠层中成骨成骨细胞的募集,从而有利于骨形成的开始。他们建立了一个模型,其中破骨细胞-冠层界面是发生骨吸收与骨形成耦合的物理部位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号